The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGenus Regulatory News (GNS)

Share Price Information for Genus (GNS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,754.00
Bid: 1,762.00
Ask: 1,768.00
Change: -42.00 (-2.34%)
Spread: 6.00 (0.341%)
Open: 1,822.00
High: 1,822.00
Low: 1,750.00
Prev. Close: 1,796.00
GNS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

17 Sep 2018 17:27

RNS Number : 0305B
Genus PLC
17 September 2018
 

17 September 2018

 

Genus plc

 

Director/PDMR Shareholding

 

Genus plc (LSE: GNS) announces that, further to the vesting of conditional nil-cost options on 14 September 2018 under the Genus 2014 Performance Share Plan (the 'PSP') and the Genus Deferred Share Bonus Plan (the 'DSBP') as listed in table A and table B below respectively, a member of the Genus Executive Leadership Team ('GELT') sold ordinary shares in Genus on 14 September 2018 on the London Stock Exchange, with income tax and social security liabilities due on the PSP exercise being deducted from the sale proceeds and the balance of funds retained, and income tax and social security liabilities due on the DSBP exercise being offset by ordinary shares sold and the balance of ordinary shares retained.

 

In addition, further to the vesting of conditional shares on 14 September 2018 under the Genus 2014 Performance Share Plan (the 'PSP') as listed in table C below, a member of the Genus Executive Leadership Team ('GELT') sold ordinary shares in Genus on 14 September 2018 on the London Stock Exchange, with income tax and social security liabilities due on the release being deducted from the sale proceeds and the balance of funds retained.

 

The below notifications, made in accordance with the requirements of the EU Market Abuse Regulation, gives further detail of the number of nil-cost options exercised and ordinary shares sold on 14 September 2018 and also the number of conditional shares released and ordinary shares sold on 14 September 2018.

 

For further information please contact:

 

Genus:

Josie Havita, Interim Deputy Company Secretary Tel: +44 (0)1256 347100

 

 

Table A - GELT 2014 Performance Share Plan Exercise

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

Jonathan Lightner

2.

Reason for the notification

a.

Position/status

Chief Scientific Officer & Head of Genus R&D

b.

Initial notification

/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Genus plc

b.

LEI

54930022EOITNKSIGH56

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the

Financial instrument, type of instrument

Identification code

Ordinary shares of 10p each

 

 

GB0002074580

b.

Nature of the transaction

Exercise of 14,375 nil-cost options under the PSP.

 

c.

Price(s) and volume(s)

Price(s)

 

0p

Volume(s)

 

14,375

 

d.

Aggregated information

· Aggregated volume

· Price

Average Price(s)

 

0p

Volume(s)

 

14,375

 

 

e.

Date of the transaction

2018-09-14

f.

Place of the transaction

Outside a trading venue.

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

 

Description of the

Financial instrument, type of instrument

Identification code

Ordinary shares of 10p each

 

GB0002074580

b.

Nature of the transaction

Sale of 14,375 shares arising from the exercise of nil-cost options under the PSP.

c.

Price(s) and volume(s)

Price(s)

 

2,506p

Volume(s)

 

14,375

 

d.

Aggregated information

· Aggregated volume

· Price

Average Price(s)

 

2,506p

Volume(s)

 

14,375

 

 

e.

Date of the transaction

2018-09-14

f.

Place of the transaction

London Stock Exchange, Main Market (XLON)

 

 

Table B - GELT Deferred Share Bonus Plan Exercise 

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

Jonathan Lightner

2.

Reason for the notification

a.

Position/status

Chief Scientific Officer & Head of Genus R&D

b.

Initial notification

/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Genus plc

b.

LEI

54930022EOITNKSIGH56

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the

Financial instrument, type of instrument

Identification code

Ordinary shares of 10p each

 

 

GB0002074580

b.

Nature of the transaction

Exercise of 3,850 nil-cost options under the DSBP.

 

c.

Price(s) and volume(s)

Price(s)

 

0p

Volume(s)

 

3,850

 

d.

Aggregated information

· Aggregated volume

· Price

Average Price(s)

 

0p

Volume(s)

 

3,850

 

 

e.

Date of the transaction

2018-09-14

f.

Place of the transaction

Outside a trading venue.

 

 

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

a.

Description of the

Financial instrument, type of instrument

Identification code

Ordinary shares of 10p each

 

 

GB0002074580

b.

b.

Nature of the transaction

Sale of 1,301 shares arising from the exercise of nil-cost options under the DSBP to offset income tax and social security liabilities due on the exercise.

c.

c.

Price(s) and volume(s)

Price(s)

 

2,505.5266p

Volume(s)

 

1,301

 

d.

d.

Aggregated information

· Aggregated volume

· Price

Price(s)

 

2,505.5266p

Volume(s)

 

1,301

 

e.

Date of the transaction

2018-09-14

f.

Place of the transaction

London Stock Exchange, Main Market (XLON)

 

 

Table C - GELT 2014 Performance Share Plan Release

5.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

Angelle Rosata

6.

Reason for the notification

a.

Position/status

Group Human Resources Director

 

b.

Initial notification

/Amendment

Initial notification

7.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Genus plc

b.

LEI

54930022EOITNKSIGH56

8.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the

Financial instrument, type of instrument

Identification code

Ordinary shares of 10p each

 

 

GB0002074580

b.

Nature of the transaction

Release of 1,499 conditional shares under the PSP.

 

c.

Price(s) and volume(s)

Average price(s)

 

0p

Total volume(s)

 

1,499

 

d.

Aggregated information

· Aggregated volume

· Price

 

Average price(s)

 

0p

Total volume(s)

 

1,499

 

e.

Date of the transaction

2018-09-14

f.

Place of the transaction

Outside a trading venue.

 

 

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

e.

a.

Description of the

Financial instrument, type of instrument

Identification code

Ordinary shares of 10p each

 

 

GB0002074580

f.

b.

Nature of the transaction

Sale of 1,499 shares arising from the release of conditional shares under the PSP.

 

g.

c.

Price(s) and volume(s)

Price(s)

 

2,500.0p

Total volume(s)

 

1,499

 

h.

d.

Aggregated information

· Aggregated volume

· Price

 

Average price(s)

 

2,500.0p

 

Total volume(s)

 

1,499

e.

Date of the transaction

2018-09-14

f.

Place of the transaction

London Stock Exchange, Main Market (XLON)

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHUBUNRWVAKAAR
Date   Source Headline
1st Feb 20161:22 pmRNSBlocklisting Interim Review
4th Jan 20165:40 pmRNSTotal Voting Rights
11th Dec 20153:14 pmRNSDirector/PDMR Shareholding
9th Dec 20154:30 pmRNSDirector/PDMR Shareholding
8th Dec 20157:00 amRNSTackles major pig disease with breakthrough tech
1st Dec 20154:54 pmRNSHolding(s) in Company
1st Dec 20154:46 pmRNSTotal Voting Rights
19th Nov 20152:52 pmRNSResult of AGM
19th Nov 20157:00 amRNSAGM - TRADING UPDATE
2nd Nov 20153:04 pmRNSTotal Voting Rights
22nd Oct 20155:48 pmRNSHolding(s) in Company
21st Oct 20156:10 pmRNSDirector/PDMR Shareholding
15th Oct 201512:46 pmRNSAnnual Report and Notice of AGM
1st Oct 20153:00 pmRNSTotal Voting Rights
15th Sep 201511:00 amRNSDirector/PDMR Shareholding
8th Sep 20157:00 amRNSPreliminary Results
3rd Aug 20152:00 pmRNSBlocklisting Interim Review
30th Jun 20152:00 pmRNSTotal Voting Rights
29th Jun 20152:00 pmRNSChange of Registered Office
29th May 20152:00 pmRNSTotal Voting Rights
12th May 20157:00 amRNSCapital Markets Event and Trading Update
11th May 20152:00 pmRNSHolding(s) in Company
7th May 20152:21 pmRNSHolding(s) in Company
30th Apr 20152:00 pmRNSTotal Voting Rights
14th Apr 20152:00 pmRNSDirector/PDMR Shareholding
13th Apr 20155:06 pmRNSHolding(s) in Company
1st Apr 20157:00 amRNSCompletion of acquisition
31st Mar 20154:04 pmRNSTotal Voting Rights
19th Mar 20155:46 pmRNSDirector/PDMR Shareholding
12th Mar 20152:09 pmRNSDirector/PDMR Shareholding
9th Mar 20151:24 pmRNSDirector Declaration
27th Feb 20152:00 pmRNSTotal Voting Rights
24th Feb 201511:00 amRNSHolding(s) in Company
24th Feb 20157:00 amRNSInterim Results
16th Feb 20157:00 amRNSAcquisition of 51% of In Vitro Brasil
2nd Feb 20151:22 pmRNSBlock Listing Six Monthly Return
31st Dec 201412:01 pmRNSTotal Voting Rights
12th Dec 201410:44 amRNSDirector/PDMR Shareholding
1st Dec 20144:36 pmRNSTotal Voting Rights
21st Nov 20144:03 pmRNSDirector/PDMR Shareholding
14th Nov 20143:42 pmRNSResult of AGM
14th Nov 20147:00 amRNSTrading Update
31st Oct 201412:20 pmRNSTotal Voting Rights
22nd Oct 20149:29 amRNSDirector/PDMR Shareholding
10th Oct 20145:58 pmRNSHolding(s) in Company
8th Oct 20143:47 pmRNSAnnual Report and Annual General Meeting
3rd Sep 20147:00 amRNSPreliminary Results
3rd Sep 20147:00 amRNSPorcine Multiplication Agreement in China
29th Aug 20143:08 pmRNSTotal Voting Rights
1st Aug 20142:00 pmRNSBlock Listing 6 Monthly Return

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.